Cystic fibrosis-related diabetes testing in Iglesias
Find health labs to test for Cystic fibrosis-related diabetes in Iglesias and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Diabetes Test by CDR Laboratorio di analisi
Via Zagabria, 60, 09129 Cagliari CA, Italia
31.7 km
Hemoglobin Test by Analisi Cliniche Amenta
Via Convento San Francesco di Paola, 91100 Trapani TP, Italia
232.6 km
Hemoglobin Test by Day Hospital
Via Francesco Crispi 86, 91025 Marsala Trapani, Italy
235.3 km
Hemoglobin Test by Analisi Cliniche Prospero Colonna Srl
Corso Duca di Genova, 26, 00121 Roma RM, Italia
273.5 km
Unverified
A Diabetes Test costs €30.00
See Details
Diabetes Test by Farmacia Internazionale di Pierandrea Cicconetti & C. Snc
Piazza Pia, 11, 00042 Anzio RM, Italia
261.4 km
Diabetes Test by Centro Analisi Sim.O. Srl
Viale Antium, 6, 00042 Anzio RM, Italia
261.4 km
Unverified
A Diabetes Test costs €15.00
See Details
Hemoglobin Test by IKON ACILIA
Via di Prato Cornelio, 200, 00125 Roma RM, Italia
273.5 km
Diabetes Test by Centro Ricerche Cliniche- Alliance Medical Diagnostic
Via Cicerone, 15, 00071 Pomezia RM, Italia
264.8 km
Hemoglobin Test by Montalto Ckech-up s.r.l.
Strada Statale Castrense Campo Morto, 312, 01014 Montalto di Castro VT, Italia
264.6 km
Unverified
A Diabetes Test costs €50.00
See Details
Diabetes Test by Centro Medico Artemisia e punto prelievi
Via Piemonte, 32, 90040 Capaci PA, Italia
265.6 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
